Fundz

PAVmed Inc. closes Series D Preferred Stock financing of $30 million and senior secured note financing of $15 million, strengthening its balance sheet.

PUBLIC · PAVMFeb 04, 2026

Amount Raised

$45 Million

Round Type

Series D

New YorkHealthcareHealth Care

Investors

Existing Long Term Investors

Description

PAVmed Inc. has announced the closing of preferred stock and senior secured note financings, totalling $45 million. The Series D Preferred Stock offering yielded $30 million, while a new senior secured note yielded $15 million. Proceeds will eliminate all previously outstanding convertible securities, enhancing the Company's balance sheet

Quick answer

PAVmed raised $45 Million in a Series D round, dated February 4, 2026. Investors: Existing Long Term Investors. PAVmed is based in New York, New York, United States.

How much did PAVmed raise?
PAVmed raised $45 Million in a Series D round on February 4, 2026.
Who invested in PAVmed?
Existing Long Term Investors is named as investors in this round.
What does PAVmed do?
PAVmed (NASDAQ: PAVM) is a highly-differentiated, multi-product medical device company employing a unique and proven business model designed to advance products from concept to commercialization much more rapidly and..
Where is PAVmed based and how big is it?
PAVmed is based in New York, New York, United States. Fundz records about 107 employees.
Who are the decision-makers at PAVmed?
Fundz holds 1 contact at PAVmed, including the Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Health Care around the same time

Companies in the same sectors as PAVmed that raised within 45 days of this round, from Fundz verified event records.

  • Tempest Therapeutics raised $2M on March 20, 2026.
  • S2N Health raised $3M (Seed) on March 19, 2026.
  • Monteris Medical raised $28M (Series E) on March 12, 2026.
  • Tenon Medical raised $4.3M on March 11, 2026.
  • Cognito Therapeutics raised $105M (Series C) on March 5, 2026.
  • Minnesota Medical Technologies raised $21M (Series A) on March 5, 2026.

Who to call at PAVmed, and when

A new round usually means PAVmed is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day PAVmed raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at PAVmed, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at PAVmed. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

PAVmed

Location

360 MADISON AVENUE

New York, New York, United States

About

PAVmed (NASDAQ: PAVM) is a highly-differentiated, multi-product medical device company employing a unique and proven business model designed to advance products from concept to commercialization much more rapidly and with significantly less capital than the typical medical device company. This model enables us to pursue an expanding pipeline strategy with a view to enhancing and accelerating value creation.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment PAVmed raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsDennis M., Executive Officer hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for PAVmed's next move

See what Strategic adds

PAVmed raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.